More than 100,000 genetic variants are reported to cause Mendelian disease in humans,
but the penetrance—the probability that a carrier of the purported disease-causing genotype …

Background Synaptic degeneration is a central pathogenic event in Alzheimer’s disease that
occurs early during the course of disease and correlates with cognitive symptoms. The pre-…

Background The ε4 allele of apolipoprotein E (APOE) gene and increasing age are two of the
most important known risk factors for developing Alzheimer disease (AD). The diagnosis of …

Background Human prion diseases are rare and usually rapidly fatal neurodegenerative
disorders, the most common being sporadic Creutzfeldt-Jakob disease (sCJD). Variants in the …

Variant CJD in a Laboratory Technician Variant Creutzfeldt–Jakob disease was identified in
a technician who had cut her thumb while handling brain sections of mice infected with …

Background Metabolic dysfunction and dysregulation of leptin signaling have been linked to
Alzheimer’s disease (AD)’s pathophysiology. The objectives of this study were to examine …

Background Synaptic dysfunction is an early core feature of Alzheimer’s disease (AD), closely
associated with cognitive symptoms. Neuregulin 1 (NRG1) is a growth and differentiation …

Background Amyloid pathology, which is one of the characteristics of Alzheimer’s disease (AD),
results from altered metabolism of the beta-amyloid (Aβ) peptide in terms of synthesis, …

Introduction The current practice of quantifying cerebrospinal fluid (CSF) biomarkers as an
aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same …

Synaptic degeneration is central in Alzheimer’s disease (AD) pathogenesis and biomarkers
to monitor this pathophysiology in living patients are warranted. We developed a novel …